Lower Starting Doses of Sorafenib Feasible for Advanced Thyroid Cancer

Published April 17, 2014

Lower Starting Doses of Sorafenib Feasible for Advanced Thyroid Cancer
A team of researchers led by Ramona Dadu, MD, at the MD Anderson Cancer Center in Houston, TX, performed a retrospective analysis to evaluate the relationship between sorafenib starting doses and first-line treatment tolerability and efficacy. … In a …
Read more on PR Web (press release)

CHI St. Luke's Health Baylor St. Luke's Medical Center begins groundbreaking …
… St. Luke's Medical Center announced today that it has begun treating patients with the groundbreaking new NeuroPace® RNS® System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Read more on Your Houston News

More Houston Drug Treatment Centers Information…